Thomas L. Goldsworthy

The Orphan Nuclear Receptor Constitutive Active/Androstane Receptor Is Essential for Liver Tumor Promotion by Phenobarbital in Mice

Hepatocellular carcinoma (HCC) is known to progress through a step often called tumor promotion. Phenobarbital (PB) is the prototype of nongenotoxic cacinogens that promote HCC in rodents. The molecular target of PB to elicit the promotion has been the subject of intense investigations over the last 30 years since it was discovered. The nuclear receptor constitutive active/androstane receptor (CAR) is activated by PB as well as by various other xenobiotics such as therapeutic drugs and environmental pollutants. CAR activation results in the transcriptional induction of numerous hepatic genes including those that encode xenobiotic-metabolizing enzymes such as a set of cytochrome P450s. In addition to PB, many CAR activators are nongenotoxic carcinogens, but the role of CAR in liver tumor promotion remains unexplored. Using Car−/− mice, we have here examined tumor promotion by chronic treatment with PB in drinking water after tumor initiation with a single dose of the genotoxic carcinogen diethylnitrosamine. None of the Car−/− mice developed either eosinophilic foci or advanced liver tumors, whereas all Car+/+ mice developed HCC and/or adenoma by 39 weeks. The results indicate that CAR is the molecular target of promotion by PB and that activation of this receptor is an essential requirement for liver tumor development.

Mutations in the ras proto-oncogene: clues to etiology and molecular pathogenesis of mouse liver tumors

The mouse liver is a frequent target organ for chemical carcinogenesis (Huff et al., 1988, 1991; Gold et al., 1989) and tumor development exhibits preferential strain sensitivity (Dragani et al., 1992; Drinkwater and Bennett, 1991). In some reports a positive correlation has been observed between the degree of spontaneous liver tumor incidence and the propensity to develop liver tumors after treatment with chemical carcinogens (Della Porta et al., 1967; Flaks, 1968; Dragani et al., 1984, 1987; Diwan et al., 1986; Drinkwater and Ginsler, 1986), but this is not always the case (Grasso and Hardy, 1975; Hanigan et al., 1988; Dragani et al., 1992). Thus, the interpretation of this endpoint in assessing potential health hazards to humans continues to be the subject of active debate. Studies of molecular and genetic factors that modulate the genesis of mouse liver tumors should enhance our understanding of the relevance of this response following exposure to genotoxic as well as nongenotoxic chemicals. To utilize intelligently animal models as surrogates for human carcinogenesis, the validity of rodent tumor endpoints in assessing potential human health hazards from chemical exposure remains an important issue. One approach has been to understand the animal system itself and the mechanisms by which chemicals induce tumors in the animal model. Information regarding the molecular events associated with tumor induction should make the relevance of results from rodent carcinogenicity studies to human risk easier to assess. Results to date have identified activation of ras proto-oncogenes as one early event and an important factor associated with chemical induction of mouse liver neoplasia (Reynolds et al., 1986, 1987; Wiseman et al., 1986), although ras-independent pathways appear to account for an appreciable proportion of some chemically induced mouse liver tumors (Fox et al., 1990; Buchmann et al., 1991). Available data emphasize the complexity of H-ras activation in murine hepatocarcinogenesis. Not only the genetic background of the mouse but also the dose of the carcinogen may influence significantly the number of tumors containing activated H-ras. Both high sensitivity and low sensitivity strains of mice can develop liver tumors which contain activated H-ras oncogenes, showing that the ability to activate this gene does not in itself determine susceptibility to hepatocarcinogenesis. Ras gene mutational profiles in chemically induced liver tumors may be different and distinguishable from those in spontaneous tumors. Since multiple genetic as well as nongenetic events are associated with tumor development, defining a precise role for ras gene mutations when they occur in mouse liver tumors is often difficult.(ABSTRACT TRUNCATED AT 400 WORDS)

Hereditary Renal Cell Carcinoma in the Eker Rat: A Rodent Familial Cancer Syndrome

A rodent model of hereditary cancer in which a single gene mutation predisposes rats to bilateral multicentric renal cell carcinoma (RCC) is described. This rat hereditary cancer syndrome shares certain similarities with von Hippel-Lindau disease (VHLD). In addition to the early development of renal epithelial tumors with morphologic similarity to human RCC, rats which bear the RCC gene are predisposed to the development of secondary primary cancers later in life. Splenic vascular proliferative lesions, including hemangiosarcoma, were seen in 23% of 14-month-old rats of both sexes that had renal tumors. At fourteen months of age, 62% of female rats with renal cell tumors had sarcomas of the lower reproductive tract of probable smooth muscle origin. Non-carrier siblings of affected animals did not have renal, reproductive, or splenic neoplasia. The finding of a specific constellation of familial neoplasms, including multicentric bilateral renal cell carcinoma, in this autosomal dominant disorder of rats suggests that this syndrome is analogous to human VHLD. In addition to its usefulness for studies of the biochemical and molecular mechanisms of renal carcinogenesis, this animal model will provide a unique tool to investigate how cancer susceptibility genes interact with environmental risk factors such as chemical carcinogens.

Chlorinated hydrocarbon-induced peroxisomal enzyme activity in relation to species and organ carcinogenicity

Trichloroethylene (TCE), perchloroethylene (PER), and pentachloroethane (PENT) are widely used industrial chemicals that cause an increased incidence of hepatocellular carcinoma in mice and a very low incidence of renal tubular adenocarcinoma in rats. A recent study (C. R. Elcombe, M. S. Rose, and I.S. Pratt (1985), Toxicol. Appl. Pharmacol. 79, 365-376) suggested that the species difference in the hepatocarcinogenicity of TCE seen between rats and mice was due to a species difference in peroxisomal proliferation and cell proliferation. The purpose of the present investigation was to understand better the association of peroxisome proliferation in the species-specific hepatocarcinogenicity, and nephrocarcinogenicity of TCE, PER, and PENT. TCE (1000 mg/kg body wt), PER (1000 mg/kg body wt), PENT (150 mg/kg body/wt), the metabolite trichloroacetic acid (TCA; 500 mg/kg body wt) or the potent peroxisome proliferating agent Wy-14,643 (WY; 50 mg/kg body wt) was administered by gavage to male F-344 rats and B6C3F1 mice for 10 days. Cyanide-insensitive palmitoyl CoA oxidation activity (PCO) was used to measure the peroxisome proliferation response. Of the chlorinated hydrocarbons, TCE and PER elevated PCO activity in mouse liver whereas only TCE elevated rat liver and kidney PCO. All agents increased PCO activity in the kidneys of mice. None of the chlorinated hydrocarbons induced a PCO response stronger than WY. These results support an association between peroxisome proliferation and hepatic tumors in mice following TCE and PER, but not PENT, administration and suggest that chlorinated hydrocarbon-induced peroxisome proliferation does not correlate with species-specific renal carcinogenicity.

The role of cell proliferation in multistage carcinogenesis.

Carcinogenesis is a complex process in which it is believed that normal cellular growth control genes are altered by sequential mutational events, with subsequent clonal growth of the resulting precancerous or cancerous cells (1, 2). The induction of mutations and the preferential clonal growth of the resulting premalignant or malignant cells, thus, become critical events in the stages of initiation, promotion, and progression in chemical carcinogenesis (Fig. 1). One class of chemical carcinogens are the genotoxicants. These compounds or their metabolites are DNA reactive and directly induce mutations or clastogenic changes. The observation that most mutagens are also carcinogenic is the basis for many current predictive assays and risk assessment models. However, there are also different classes of nongenotoxic carcinogens that do not interact with the DNA. The class designated as mitogens directly induces cell proliferation in the target tissue. Another class, the cytotoxicants, produces cell death followed by regenerative cell proliferation. For the mitogens and cytotoxicants, differential toxicity and growth stimulation may provide a preferential growth advantage to spontaneous or chemically induced precancerous or cancerous cells. Furthermore, mutagens are much more effective as carcinogens at doses that also induce cell proliferation. Mutational activity may occur as an event secondary to cell proliferation caused by the mitogens or cytotoxicants. Thus, chemically induced cell proliferation is an important mechanistic consideration for the genotoxic and nongenotoxic carcinogens. Both genotoxic activity and induced cell proliferation have been associated with the known human chemical carcinogens (3, 4). Knowledge of the relationship of induced cell proliferation to carcinogenic activity would be valuable in setting doses for cancer bioassays, classifying chemical carcinogens, and providing more realistic carcinogenic risk assessments. Initiation Initiation represents initial or early events in the carcinogenic process that predispose a cell to malignant transformation.

Potential role of α-2μ-globulin, protein droplet accumulation, and cell replication in the renal carcinogenicity of rats exposed to trichloroethylene, perchloroethylene, and pentachloroethane

Trichloroethylene (TCE), perchloroethylene (PER), and pentachloroethane (PENT) are used extensively as industrial solvents. These agents cause an increased incidence of renal tumors in male, but not female, rats. Male and female F-344 rats were gavaged for 10 days with TCE (1000 mg/kg), PER (1000 mg/kg), and PENT (150 mg/kg) to determine if chlorinated hydrocarbon-induced changes in levels of renal alpha-2 mu-globulin (alpha 2 mu), protein droplet accumulation (PDA), and cell replication were male rat specific. The animal strain, dose, and route of administration were the same as previous chronic bioassays in order to better understand the relationship between alpha 2 mu, PDA, and cell replication to the sex-specific renal carcinogenicity. In male rats, increases in protein droplet and crystalloid accumulation in the cytoplasm of the P2 segment of the proximal tubule were evident after PER and more notably PENT administration. Cell replication rates in male rats increased specifically in the histologically damaged P2 segments after PER or PENT exposure. Protein droplets and cell replication did not differ from controls in TCE-treated male rats or in female rats treated with TCE, PER, or PENT. Immunohistochemical staining for alpha 2 mu revealed a marked correlation between the presence of alpha 2 mu and the protein droplets. Renal alpha 2 mu concentrations in male rats increased after PER or PENT but not TCE administration. The protein droplet nephropathy induced in male rats after PER and PENT treatment appears identical to that observed with other male-rat-specific renal carcinogens such as unleaded gasoline. The differences observed in male and female rats after chlorinated hydrocarbon exposure suggest that increases in cell replication may be directly linked to the male-rat-specific protein alpha 2 mu. Since compensatory cell division is postulated to affect all stages of the carcinogenic process, the increased incidence of renal tumors in male rats after PER or PENT treatment may be related to nephrotoxicity and resulting enhanced cell replication. Mechanisms involved in TCE-induced renal carcinogenicity appear to be different from PER- and PENT-induced renal carcinogenicity.

Apoptosis and cancer risk assessment.

Apoptosis is one form of physiological or active cell death. The balance between cell proliferation and cell death or apoptosis not only effects organ growth but also has a profound impact on the net increase and growth of initiated cells and preneoplastic and tumor cell populations. With respect to cancer development apoptosis is becoming widely recognized as being an innate tissue defense against carcinogens by inhibiting survival and controlling growth of precancerous cell populations and tumors at different stages of carcinogenesis. Experimental data on cell birth and cell death rates help identify the mode of action of a chemical and can be incorporated into biologically based cancer models. This article describes the quantitation and regulation of apoptosis in rodent liver and how loss of regulation can have a role in hepatocarcinogenesis. A biologically-based mouse liver cancer model is presented and utilized to describe how treatment related growth effects affect the process of carcinogenesis. Advantages and limitations of biologically based cancer models in cancer research and risk assessment are discussed.

Importance of and approaches to quantification of hepatocyte apoptosis

Abnormal regulation of the life cycle of cells is a key feature of neoplasia. The net increase and growth of initiated cells, preneoplastic lesions, and tumors is highly dependent on rates of both cell proliferation and cell death. Studies of mechanisms involved in regulation of cell death and the development of methods to detect dying and dead cells thus appear to be as important as measurements of cell proliferation in understanding the growth of both normal, preneoplastic and neoplastic lesions. This article describes apoptosis in the mouse liver and its potential role in liver carcinogenesis. Quantitation of hepatocyte apoptosis is a emerging and evolving research area that will require evaluations as thoroughly as those performed with cell proliferation in order to understand all the variables that might influence its occurrence, measurement, and interpretations. Utilizing available data, various methodologies for identifying hepatocyte apoptosis are presented and compared, Aspects important for the quantitation of apoptosis in liver are emphasized. Accurate quantitation of apoptosis, in conjunction with proliferation measurements, is critical for investigations of the mechanisms of chemically induced carcinogenesis and the development of assays for growth alterations and can be applied to biologically based cancer models.

Variation in expression of genes used for normalization of Northern blots after induction of cell proliferation

Quantitative knowledge of gene expression can provide valuable information for understanding the action of chemicals that alter cell proliferation and cancer. Accurate quantification of mRNA levels requires the normalization of the gene of interest to a gene with transcriptional levels that do not vary through the cell cycle or with a particular treatment. Changes in expression were examined in proliferating or non‐proliferating rat liver for three constitutively expressed ‘housekeeping’ genes commonly used to normalize mRNA levels from Northern blots. In addition, a direct method of quantifying poly(A)+ mRNA by hybridization with a radiolabelled polythymidylate—poly(T)—probe was compared with traditional methods. Hepatocyte cytolethality and a subsequent wave of hepatocyte proliferation were induced in male Fischer‐344 rats by treatment with a single gavage dose of carbon tetrachloride. Induced cell proliferation peaked at 48 h after treatment. Expression of the housekeeping genes actin, glyceraldehyde‐3‐phosphate‐dehydrogenase (GAPDH) and albumin, as well as the proto‐oncogene H‐ras, was determined by Northern blot analysis at times from 0.5 h to 4 days after treatment. Time‐dependent changes were observed in the expression of these genes relative to the levels observed in the untreated control animals. Actin expression peaked at 3.4‐fold over control and GAPDH expression was increased by 1.9‐fold over control. Albumin mRNA levels varied the least, 1.4‐fold over control, indicating that this gene is more appropriate than actin or GAPDH for normalization of proto‐oncogene expression under experimental conditions that induce cell proliferation in rat liver. The direct quantification of poly(A)+ mRNA using a poly(T) probe was not influenced by the induction of cell proliferation. This method may be useful when the expression of housekeeping genes is affected by treatment.

Boron supplementation inhibits the growth and local expression of IGF-1 in human prostate adenocarcinoma (LNCaP) tumors in nude mice.

Prostate-specific antigen (PSA) is a serine protease and one of the most abundant proteins secreted by the human prostate epithelium. PSA is used as a well-established marker of prostate cancer. The involvement of PSA in several early events leading to the development of malignant prostate tumors has made it a target for prevention and intervention. It is thought that PSA cleaves insulin-like growth factor binding protein-3 (IGFBP-3), providing increased local levels of IGF-1, leading to tumor growth. Separately, there are data that suggest an enzymatic regulatory role for dietary boron, which is a serine protease inhibitor. In this study we have addressed the use of boric acid as a PSA inhibitor in an animal study. We have previously reported that low concentrations (6 ug/mL) of boric acid can partially inhibit the proteolytic activity of purified PSA towards a synthetic fluorogenic substrate. Also, by Western blot we have followed the degradation of fibronectin by enzymatically active PSA and have found significant inhibition in the presence of boric acid. We proposed that dietary supplementation with boric acid would inhibit PSA and reduce the development and proliferation of prostate carcinomas in an animal model. We tested this hypothesis using nude mice implanted subcutaneously with LNCaP cells in Matrigel. Two groups (10 animals/group) were dosed with boric acid solutions (1.7, 9.0 mgB/kg/day) by gavage. Control group received only water. Tumor sizes were measured weekly for 8 weeks. Serum PSA and IGF-1 levels were determined at terminal sacrifice. The size of tumors was decreased in mice exposed to the low and high dose of boric acid by 38% and 25%, respectively. Serum PSA levels decreased by 88.6% and 86.4%, respectively, as compared to the control group. There were morphological differences between the tumors in control and boron-dosed animals, including a significantly lower incidence of mitotic figures in the boron-supplemented groups. Circulating IGF-1 levels were not different among groups, though expression of IGF-1 in the tumors was markedly reduced by boron treatment, which we have shown by immunohistochemistry. These data indicate that low-level dietary boron supplementation reduced tumor size and content of a tumor trophic factor, IGF-1.This promising model is being evaluated in further studies.